PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30862488-0	2019	Drug library screen reveals benzimidazole derivatives as selective cytotoxic agents for KRAS-mutant lung cancer.	benzimidazole	28-41	KRAS proto-oncogene, GTPase	Homo sapiens	88-92	
30862488-6	2019	The screening identified the cytotoxic effects of benzimidazole derivatives on KRAS-mutant lung cancer cells.	benzimidazole	50-63	KRAS proto-oncogene, GTPase	Homo sapiens	79-83	
30862488-7	2019	Treatments with two benzimidazole derivatives, methiazole and fenbendazole-both of which are structurally specific-yielded significant suppression of the RAS-related signaling pathways in KRAS-mutated cells.	benzimidazole	20-33	KRAS proto-oncogene, GTPase	Homo sapiens	188-192	
30862488-9	2019	Our study demonstrates that these benzimidazole derivatives play an important role in suppressing KRAS-mutant lung cancer cells, thus offering a novel combinatorial therapeutic approach against such cancer cells.	benzimidazole	34-47	KRAS proto-oncogene, GTPase	Homo sapiens	98-102